Halozyme Therapeutics reported $55.98M in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Amarin AMRN:US $ 309.27M 36.81M
Amgen AMGN:US $ 4152M 37M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Baxter International BAX:US $ 2025M 40M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Esperion Therapeutics ESPR:US $ 33.97M 10.26M
Halozyme Therapeutics HALO:US $ 55.98M 2.58M
Intra Cellular Therapies ITCI:US $ 8.17M 0.4M
Intrexon XON:US $ 9.94M 1.48M
JAZZ PHA JAZZ:US $ 1137.85M 113.41M
Mannkind MNKD:US $ 7.48M 0M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Peregrine Pharmaceuticals PPHM:US $ 15.24M 3.37M
United Therapeutics UTHR:US $ 96.7M 6.8M
Vanda Pharmaceuticals VNDA:US 902K 153K